Oppenheimer analyst Suraj Kalia lowered the price target on TransMedics Group (NASDAQ: TMDX) to $125.00 (from $200.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

After-hours movers: Ford, V.F. Corp, F5 Networks, Cadence Design and moreOctober 28, 2024 4:42 PM Form 8-K TransMedics Group, Inc. For: Oct 28October 28, 2024 4:11 PM TransMedics Group (TMDX) Misses Q3 EPS by 17c, Updates GuidanceOctober 28, 2024 4:11 PM TransMedics Reports Third Quarter 2024 Financial ResultsOctober 28, 2024 4:05 PM TD Cowen Reiterates Buy Rating on TransMedics Group (TMDX)October 25, 2024 7:46 AM